HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feng Li Selected Research

phenylahistin

1/2020Structure-based design and synthesis of novel furan-diketopiperazine-type derivatives as potent microtubule inhibitors for treating cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Feng Li Research Topics

Disease

620Neoplasms (Cancer)
11/2022 - 03/2002
111Inflammation (Inflammations)
09/2022 - 06/2007
100Infections
12/2022 - 07/2003
90Neoplasm Metastasis (Metastasis)
11/2022 - 05/2003
88Breast Neoplasms (Breast Cancer)
04/2022 - 03/2002
72Carcinogenesis
06/2022 - 02/2003
55Hepatocellular Carcinoma (Hepatoma)
06/2022 - 06/2006
54Stomach Neoplasms (Stomach Cancer)
05/2022 - 07/2009
47Carcinoma (Carcinomatosis)
01/2022 - 07/2005
41Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2010
37Fibrosis (Cirrhosis)
10/2022 - 08/2004
36Esophageal Squamous Cell Carcinoma
01/2022 - 12/2009
34Prostatic Neoplasms (Prostate Cancer)
11/2022 - 01/2005
33Glioma (Gliomas)
06/2022 - 06/2006
31Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2009
28Hypoxia (Hypoxemia)
01/2021 - 12/2003
27Lung Neoplasms (Lung Cancer)
06/2022 - 02/2003
26Body Weight (Weight, Body)
04/2022 - 08/2005
26Nasopharyngeal Carcinoma
01/2022 - 04/2004
25COVID-19
12/2022 - 01/2020
25Pneumonia (Pneumonitis)
11/2022 - 09/2012
25Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 07/2009
24Esophageal Neoplasms (Esophageal Cancer)
11/2022 - 10/2007
24Insulin Resistance
01/2022 - 04/2006
24Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2010
23Lymphatic Metastasis
10/2022 - 01/2008
22Obesity
04/2022 - 02/2005
21Human Influenza (Influenza)
01/2022 - 07/2003
21Virus Diseases (Viral Diseases)
01/2022 - 07/2005
21Wounds and Injuries (Trauma)
01/2021 - 08/2006
19Hypertension (High Blood Pressure)
05/2022 - 02/2005
19Alzheimer Disease (Alzheimer's Disease)
12/2021 - 11/2002
18Melanoma (Melanoma, Malignant)
11/2022 - 10/2003
18Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 05/2005
17Multiple Myeloma
05/2022 - 10/2010
17Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2021 - 01/2012
16Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 03/2005
16Osteoporosis
01/2022 - 02/2007
15Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 12/2004
15Asthma (Bronchial Asthma)
01/2022 - 07/2007
15Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2009
14Liver Diseases (Liver Disease)
07/2022 - 08/2008
14Hyperglycemia
06/2022 - 02/2011
14Fatigue
05/2022 - 05/2010
14Neurodegenerative Diseases (Neurodegenerative Disease)
03/2022 - 01/2003
14Pain (Aches)
12/2021 - 01/2010
14Leukemia
12/2021 - 09/2005
14Necrosis
01/2021 - 03/2008
13Glioblastoma (Glioblastoma Multiforme)
06/2022 - 01/2015

Drug/Important Bio-Agent (IBA)

252Proteins (Proteins, Gene)FDA Link
11/2022 - 03/2002
143Biomarkers (Surrogate Marker)IBA
09/2022 - 01/2008
89Pharmaceutical PreparationsIBA
06/2022 - 01/2008
84Messenger RNA (mRNA)IBA
05/2022 - 03/2002
75Biological ProductsIBA
05/2022 - 07/2003
74MicroRNAs (MicroRNA)IBA
06/2022 - 04/2011
66CytokinesIBA
12/2022 - 08/2004
47DNA (Deoxyribonucleic Acid)IBA
06/2022 - 08/2003
45Glucose (Dextrose)FDA LinkGeneric
01/2022 - 04/2004
38Long Noncoding RNAIBA
11/2022 - 01/2014
33RNA (Ribonucleic Acid)IBA
04/2022 - 09/2005
30AntigensIBA
05/2022 - 06/2010
30LigandsIBA
02/2022 - 03/2002
30EnzymesIBA
01/2022 - 08/2008
28LipidsIBA
01/2022 - 08/2003
28Peptides (Polypeptides)IBA
12/2021 - 04/2004
27Therapeutic UsesIBA
08/2022 - 07/2007
26ParaffinIBA
11/2021 - 08/2003
24Antiviral Agents (Antivirals)IBA
12/2022 - 02/2004
24VaccinesIBA
12/2022 - 07/2003
22Insulin (Novolin)FDA Link
01/2022 - 10/2007
21p21-Activated KinasesIBA
06/2022 - 08/2002
21Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2006
21Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 11/2005
20Phosphotransferases (Kinase)IBA
06/2022 - 06/2005
20OzoneIBA
01/2022 - 05/2011
19CateninsIBA
01/2022 - 01/2012
19Small Interfering RNA (siRNA)IBA
01/2022 - 03/2005
19Formaldehyde (Formol)FDA Link
01/2019 - 08/2003
18AlbuminsIBA
09/2022 - 04/2012
18Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 03/2008
17Triglycerides (Triacylglycerol)IBA
01/2022 - 02/2005
17Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 05/2007
16Interleukin-6 (Interleukin 6)IBA
12/2022 - 07/2014
16AntibodiesIBA
05/2022 - 06/2007
16Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 02/2011
15Indicators and Reagents (Reagents)IBA
10/2022 - 10/2007
15Oxygen (Dioxygen)IBA
01/2022 - 12/2003
15Inosine Triphosphate (ITP)IBA
02/2021 - 01/2012
15CollagenIBA
01/2021 - 01/2002
14Cisplatin (Platino)FDA LinkGeneric
03/2022 - 11/2004
14CholesterolIBA
01/2022 - 02/2005
13Carrier Proteins (Binding Protein)IBA
11/2022 - 03/2002
13AcidsIBA
01/2022 - 07/2010

Therapy/Procedure

198Therapeutics
05/2022 - 09/2005
60Drug Therapy (Chemotherapy)
11/2022 - 01/2009
35Immunotherapy
11/2022 - 06/2007
23Radiotherapy
05/2022 - 07/2010
21Lasers (Laser)
04/2022 - 02/2003
16Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 04/2011
15Stents
08/2022 - 01/2009